Oncternal Therapeutics - 53 Year Dividend History | ONCT
Historical dividend payout and yield for Oncternal Therapeutics (ONCT) since 1971. The current TTM dividend payout for Oncternal Therapeutics (ONCT) as of April 17, 2024 is $0.00. The current dividend yield for Oncternal Therapeutics as of April 17, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.023B |
$0.001B |
|
Oncternal Therapeutics Inc. is a clinical-stage oncology company. It is engaged in developing treatments for cancers with critical unmet medical need. The company's pipeline includes cirmtuzumab, TK-216 and CAR-T therapy that targets ROR1 which are in clinical stage. Oncternal Therapeutics Inc., formerly known as GTx Inc., is based in San Diego, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
